Outcomes from COVID-19 Clinical Trials in Hospitalized Patients: Seeking the Truth That Matters
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Tong A, Elliott J, Azevedo L, Baumgart A, Bersten A, Cervantes L
. Core Outcomes Set for Trials in People With Coronavirus Disease 2019. Crit Care Med. 2020; 48(11):1622-1635.
PMC: 7448717.
DOI: 10.1097/CCM.0000000000004585.
View
2.
Jin X, Pang B, Zhang J, Liu Q, Yang Z, Feng J
. Core Outcome Set for Clinical Trials on Coronavirus Disease 2019 (COS-COVID). Engineering (Beijing). 2020; 6(10):1147-1152.
PMC: 7102592.
DOI: 10.1016/j.eng.2020.03.002.
View
3.
Murray D, Babiker A, Baker J, Barkauskas C, Brown S, Chang C
. Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3). Clin Trials. 2021; 19(1):52-61.
PMC: 8847314.
DOI: 10.1177/17407745211049829.
View
4.
. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020; 20(8):e192-e197.
PMC: 7292605.
DOI: 10.1016/S1473-3099(20)30483-7.
View
5.
Qiu R, Zhao C, Liang T, Hao X, Huang Y, Zhang X
. Core Outcome Set for Clinical Trials of COVID-19 Based on Traditional Chinese and Western Medicine. Front Pharmacol. 2020; 11:781.
PMC: 7265660.
DOI: 10.3389/fphar.2020.00781.
View